1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea
CAS: 1333390-56-9
Ref. 3D-IDC39056
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
Regorafenib is a multikinase inhibitor that inhibits the activity of kinases in the RAS-RAF-MEK-ERK pathway, which are enzymes that regulate cell proliferation. It is an oral drug used to treat patients with metastatic colorectal cancer who have been previously treated with chemotherapy. The target of regorafenib is the oncogenic kinases in the RAS-RAF-MEK-ERK pathway, which are important for tumor growth and progression. Regorafenib has shown efficacy against many different types of cancers, including colorectal, thyroid, lung and renal cancers.
Propiedades químicas
Consulta técnica sobre: 3D-IDC39056 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
